Publications by authors named "Christopher Edwards"

Objective: To propose a new definition for SLEDAI arthritis informed by imaging.

Methods: We performed a planned secondary analysis of observational data from a multicentre study evaluating SLE patients with inflammatory joint pain (swelling not required) using various clinical instruments, laboratory tests and ultrasound. For SLEDAI arthritis, assessors (blinded to ultrasound) were asked which of the glossary terms for arthritis in any version of the SLEDAI drove their decision to score for arthritis.

View Article and Find Full Text PDF

Aims: We sought to characterize the clinical course of patients following worsening heart failure (WHF) treated in an outpatient setting and to identify factors associated with a poor response to standard of care with loop diuretics.

Methods And Results: Between September 2022 and March 2023, 44 eligible patients (mean age 66.3 years, 84% male) with ejection fraction <50% and with WHF symptoms in the preceding week treated in an outpatient setting were enrolled.

View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a profound global impact. The emergence of several variants during the pandemic has presented numerous challenges in preventing and managing this disease. The development of vaccines has played a pivotal role in controlling the pandemic, with a significant portion of the global population being vaccinated.

View Article and Find Full Text PDF

Objectives: Hydrazine (HZ) and Hydrazine Derivative (HZ-D) exposures pose health risks to people in industrial and aerospace settings. Several recent systematic reviews and case series have highlighted common clinical presentations and management strategies. Given the low frequency at which HZ and HZ-D exposures occur, a strong evidence base on which to develop an evidence-based guideline does not exist at this time.

View Article and Find Full Text PDF

Background: The impact of cleft and craniomaxillofacial (CCMF) surgeons on oral and maxillofacial surgery (OMS) resident training is not well known.

Purpose: The purpose of this study was to measure the association between resident exposure to OMS faculty with CCMF surgery training, clinical experience, and scholarly activity.

Study Design, Setting, Sample: An anonymous survey of OMS residency directors in the United States, distributed electronically by the American Association of Oral and Maxillofacial Surgeons, was used to conduct a cross-sectional study.

View Article and Find Full Text PDF
Article Synopsis
  • One-way alphanumeric pagers are still widely used in healthcare, especially among OMS residents, despite the rise of modern communication apps; frequent nonurgent paging can disrupt workflows and potentially harm patient care.
  • The study aimed to investigate how paging patterns among OMS residents varied throughout the day by analyzing paging data from Emory Healthcare over two years.
  • Results showed a significant number of pages were received during designated peak hours, with an average of 18.8 pages daily in 2021, suggesting variations in paging rates that could affect resident workloads and patient interaction.
View Article and Find Full Text PDF
Article Synopsis
  • * The disease has periods of relapse and remission, and recent drug development has led to new treatments like belimumab, anifrolumab, and voclosporin, yet there remains a need for innovative solutions.
  • * JAK inhibitors, which are targeted oral therapies showing promise for various diseases, are currently being researched as potential treatments for SLE, with the paper summarizing clinical trial and case report data on their efficacy.
View Article and Find Full Text PDF
Article Synopsis
  • A study looked at how steroids, like prednisone, help reduce congestion in patients with acute heart failure (AHF).
  • Patients taking prednisone showed more improvement in their congestion levels compared to those receiving regular care.
  • The results suggest that steroids can help with symptoms related to congestion, but more research is needed to confirm these findings.
View Article and Find Full Text PDF
Article Synopsis
  • Tyk2, part of the JAK kinase family, plays a key role in inflammation and is linked to autoimmune disorders.
  • Targeting Tyk2 selectively could lead to fewer side effects than traditional JAK inhibitors, prompting increased research into its therapeutic potential.
  • The drug Deucravacitinib is now approved for psoriasis, and other Tyk2 inhibitors are being studied for various autoimmune diseases like psoriatic arthritis and inflammatory bowel disease.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied a medicine called filgotinib to see if it helps people with moderately active rheumatoid arthritis (RA) who weren't getting better with other treatments.
  • They tested filgotinib against a placebo and another medicine called adalimumab, finding that more patients on filgotinib felt better and had less disease activity after 12 and 24 weeks.
  • The safety of filgotinib was similar to adalimumab, with infections being the most common side effect, and the benefits lasted for at least a year.
View Article and Find Full Text PDF

Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that primarily affects middle-aged individuals but is increasingly prevalent among the elderly due to longer life expectancies. Treating elderly onset RA (EORA) is challenging for clinicians because of unique disease characteristics, comorbidities, polypharmacy, age-related physiological changes, and limited studies on the safety and efficacy of biological therapies in this population. This review aims to evaluate the use of various biological therapies in elderly RA patients.

View Article and Find Full Text PDF
Article Synopsis
  • - Anemia is a common issue among heart failure patients, affecting their treatment outcomes, and this study aimed to examine how anemia prevalence changes and its relationship with clinical results in heart failure patients from the STRONG-HF study.
  • - In the study of 1077 patients, anemia rates rose from 27.2% at enrollment to 32.1% at 90 days, with a slightly higher primary composite outcome observed in anemic patients, but the difference wasn't statistically significant.
  • - Patients with baseline anemia showed less improvement in health-related quality of life, while the incidence of anemia was higher in those receiving high-intensity care compared to usual care; factors like male sex and non-European regions were linked to a higher
View Article and Find Full Text PDF

This report describes a case of retinal vasculitis in a patient with autoimmune lymphoproliferative syndrome (ALPS). A 13-year-old girl undergoing work-up for immune dysregulation was referred for retinal vasculitis. The patient was asymptomatic on presentation, but her retinal examination was remarkable for areas of outer retinal and choriocapillary loss and focal vascular inflammation.

View Article and Find Full Text PDF
Article Synopsis
  • * Patients receiving prednisone showed a significant reduction in inflammation as indicated by decreased levels of high-sensitivity C-reactive protein (hsCRP) and a notably lower risk of heart failure worsening, readmissions, or death over 90 days compared to the usual care group.
  • * While burst steroid therapy improved outcomes like quality of life and reduced heart failure risks, it was associated with more adverse events like hyperglycemia, indicating a need for larger studies to confirm these findings and further assess safety
View Article and Find Full Text PDF

Background: Ex vivo perfusion of transplant-declined human organs has emerged as a promising platform to study the response of an organ to novel therapeutic strategies. However, to fully realize the capability of this platform for performing translational research in human organ pathophysiology, there is a need for robust assays to assess organ function and disease. State-of-the-art research methods rely on analyses of biopsies taken during perfusion, which both damages the organ and only provides localized information.

View Article and Find Full Text PDF

: The utility of shear wave elastography (SWE) as an adjunct to ultrasound biometry and Doppler velocimetry for the examination of placental dysfunction and suboptimal fetal growth is unclear. To date, limited data exist correlating the mechanical properties of placentae with fetal growth. This study aimed to investigate the relationship between placental shear wave velocity (SWV) and ultrasound estimated fetal weight (EFW), and to ascertain if placental SWV is a suitable proxy measure of placental function in the surveillance of small-for-gestational-age (SGA) pregnancies.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the potential benefits of methotrexate, an antirheumatic drug, in treating knee osteoarthritis (KOA) pain through a multicenter, double-blind, placebo-controlled trial involving 207 participants.
  • Participants were randomly assigned to receive either methotrexate or a placebo for 12 months while continuing their usual pain relief medications, with a primary focus on assessing average knee pain at 6 months.
  • Results indicated that the methotrexate group experienced a significant decrease in knee pain compared to the placebo group, suggesting methotrexate may provide symptomatic relief for KOA.
View Article and Find Full Text PDF
Article Synopsis
  • The STRONG-HF trial tested the effectiveness of rapidly increasing neurohormonal blockade in patients with acute heart failure (AHF) compared to usual care.
  • Patients receiving high-intensity care (HIC) showed significantly higher rates of successful decongestion at day 90 (75%) compared to usual care (68%), alongside improvements in various decongestion markers.
  • Successful decongestion was linked to a lower risk of hospital readmission or all-cause death, indicating that the HIC approach offers better long-term outcomes for AHF patients.
View Article and Find Full Text PDF

Aims: Inflammation has emerged as a potential key pathophysiological mechanism in heart failure (HF) in general and acute HF (AHF) specifically, with inflammatory biomarkers shown to be highly predictive of adverse outcomes in these patients. The CORTAHF study builds on both these data and the fact that steroid burst therapy has been shown to be effective in the treatment of respiratory diseases and COVID-19. Our hypothesis is that in patients with AHF and elevated C-reactive protein (CRP) levels without symptoms or signs of infection, a 7-day course of steroid therapy will lead to reduced inflammation and short-term improvement in quality of life and a reduced risk of worsening HF (WHF) events.

View Article and Find Full Text PDF